about
CRASH-2 Study of Tranexamic Acid to Treat Bleeding in Trauma Patients: A Controversy Fueled by Science and Social MediaApplying results from clinical trials: tranexamic acid in trauma patientsTranexamic acid: from trauma to routine perioperative useMechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial.Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis.Tranexamic acid and trauma-induced coagulopathy.Trauma-Induced Coagulopathy: An Institution's 35 Year Perspective on Practice and Research.Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapyPostinjury fibrinolysis shutdown: Rationale for selective tranexamic acidDesign of the Study of Tranexamic Acid during Air Medical Prehospital Transport (STAAMP) Trial: Addressing the Knowledge Gaps.Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity.Tranexamic Acid Reduces Hidden Blood Loss in Patients Undergoing Total Knee Arthroplasty: A Comparative Study and Meta-Analysis.Tranexamic Acid Use in United States Children's HospitalsTranexamic acid in bleeding trauma patients: an exploration of benefits and harms.Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy.Compliance of tranexamic acid administration to trauma patients at a level-one trauma centre.Effectiveness of early administration of tranexamic acid in patients with severe trauma.Management of Trauma-Induced Coagulopathy with Thrombelastography.USE OF TRANEXAMIC ACID IN TRAUMA PATIENTS: AN ANALYSIS OF COST-EFFECTIVENESS FOR USE IN BRAZIL.Remote Damage Control Resuscitation in Austere Environments.Tranexamic Acid Use in Prehospital Uncontrolled Hemorrhage.Massive hemorrhage and transfusion in the operating room.Emerging strategies to treat ruptured abdominal aortic aneurysms.[Uncritical use of tranexamic acid in trauma patients : Do no further harm!]Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient.Monitoring bypassing agent therapy - a prospective crossover study comparing thromboelastometry and thrombin generation assay.Administration of tranexamic acid in trauma patients under stricter inclusion criteria increases the treatment window for stabilization from 24 to 48 hours-a retrospective review.A copper(II) paddle-wheel structure of tranexamic acid: di-chloro-tetra-kis-[μ-4-(ammonio-meth-yl)cyclo-hexane-1-carboxyl-ato-O,O']dicopper(II) dichloride hexa-hydrate.Haematological factors in the management of adult epistaxis: systematic review.Fibrinolysis in trauma: a review.Tranexamic Acid Prophylaxis in Hip and Knee Joint Replacement.Approach to Hemoptysis in the Modern Era.Damage Control Resuscitation.Experimental Evaluation of Tranexamic Acid-Loaded Porous Starch as a Hemostatic Powder.A Fibrin Cross-linking Polymer Enhances Clot Formation Similar to Factor Concentrates and Tranexamic Acid in an in vitro Model of Coagulopathy.Tranexamic acid for trauma: Filling the ‘GAP’ in evidence
P2860
Q26785966-B1FE7801-323F-4403-9833-9D030269B904Q28082587-4E5A7347-827B-44A6-9157-8892EF2D9D7FQ28083660-1C17E291-D4CC-4833-ACE5-54479103AB36Q30877676-537DF716-A167-462A-846A-3E684844A446Q33676496-66CD13E6-BA80-403B-A758-9C172F1ABC40Q33919354-4811998B-28C0-4D0B-B867-2737BA9DB77DQ34429408-CC8819DA-9EF2-4EF2-9187-2477005F8F79Q35207771-27559B58-47A4-4835-8A7C-FB8F3BAC84AAQ35646892-6F9E0277-4387-4B0A-AB4D-7E5DDC48C450Q36215702-C28782DF-C573-439F-ACE5-D97AF153195FQ36461468-E0182DDC-6460-44AE-8D54-6DEF85A6309FQ36683282-3621D5F8-A3FC-4566-9C95-92DE3322CD73Q37017257-16BCA9A3-E8AB-4F23-B0CA-ACE15F7F0AFCQ37615859-7F9E5207-76D4-430E-AD06-B8453FE73716Q37731832-C29CF543-D888-4FA2-9135-DD121AB4183BQ38695764-A81AA05D-2E9F-47E0-BB78-A38AD611939BQ38946580-742A30F4-D1DF-4067-A1C2-352673B4324CQ39022502-5C323239-F30D-497D-BC36-231942DC5B72Q39027030-46EE6568-67B6-46FF-9B32-744BB7B5A408Q39364087-711F53DE-F31E-48DD-92D2-4D89C53E64CCQ39364102-0D0BE049-E384-4689-A3B5-2EBDCEF1F3DFQ39441037-637C0209-A424-449A-B56B-11CA458DB8E7Q40407071-3811D18A-955A-47AE-89AD-CCC7795357C1Q40577604-730870F1-137F-4AEE-A3CD-EC69CC9BA1F0Q45375279-E7FED3BB-7420-4207-8BB0-C59444E6F193Q45871315-E3F7E036-96D5-4953-9687-B24888EC002DQ46580866-D440E9C7-5474-4AB7-B5D3-6EA45991A200Q47098948-6C3629D2-F6BD-4579-9B9D-93A86C226E7CQ47217356-29EA7AE5-2BB0-4FD3-A8FA-5BCFEE90C2B5Q47251777-4D9E3E0A-FBF1-427E-9C01-670D9E41B082Q47295775-6276134C-FF98-4B62-A7D4-617DCCE86FA2Q49874140-DE781ED3-31AF-46DB-BA92-CB34CF11B298Q50457260-DD6E09BA-EB24-42D0-BE2E-52D3CF03DCF1Q53150324-38B3ED60-1176-4014-856B-54FEF6DA63B8Q55038787-BCC4A90A-7674-4048-B42C-F5477E3DAEC0Q58489118-2B1DE2D6-A94A-4708-91FC-FA6C53025E42
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Tranexamic acid in trauma: how should we use it?
@ast
Tranexamic acid in trauma: how should we use it?
@en
Tranexamic acid in trauma: how should we use it?
@nl
type
label
Tranexamic acid in trauma: how should we use it?
@ast
Tranexamic acid in trauma: how should we use it?
@en
Tranexamic acid in trauma: how should we use it?
@nl
prefLabel
Tranexamic acid in trauma: how should we use it?
@ast
Tranexamic acid in trauma: how should we use it?
@en
Tranexamic acid in trauma: how should we use it?
@nl
P2093
P1476
Tranexamic acid in trauma: how should we use it?
@en
P2093
Bryan A Cotton
Ernest E Moore
Lena M Napolitano
Martin A Schreiber
Mitchell J Cohen
P304
P356
10.1097/TA.0B013E318292CC54
P577
2013-06-01T00:00:00Z